Coverage
-
May 24, 2016
AstraZeneca AB on Monday urged a New Jersey federal court to dismiss Dr. Reddy's Laboratories suit alleging it wrongfully blocked the generics maker from using a purple capsule for its version of Nexium, saying a Delaware federal court already decided the issue by enjoining Dr. Reddy's use of the purple marks.
2 other articles on this case.
View all »